GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Deferred Tax

Baskhanbiopharma (XKRX:354390) Deferred Tax : ₩-27 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Baskhanbiopharma's change in deferred tax for the six months ended in Dec. 2024 was ₩-27 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-27 Mil.

Baskhanbiopharma Deferred Tax Historical Data

The historical data trend for Baskhanbiopharma's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma Deferred Tax Chart

Baskhanbiopharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax
-440.00 - - -1,515.76 -26.63

Baskhanbiopharma Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax -440.00 - - -1,515.76 -26.63

Baskhanbiopharma Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-27 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baskhanbiopharma Deferred Tax Related Terms

Thank you for viewing the detailed overview of Baskhanbiopharma's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Baskhanbiopharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Deferred Tax
Comparable Companies
XKRX:018620 XKRX:318010 XKRX:034940 XKRX:233250 XKRX:336040 XKRX:018680 XKRX:900120 XKRX:053950 XKRX:200230 XKRX:314140 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR
Website
https://www.baskhanbio.com
Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma Headlines

No Headlines